Novo Nordisk’s attempt to create a successor to its weight loss blockbuster Wegovy may have taken a hit with recent ...

After 12 weeks, weight loss with the drug was 13% of body weight, compared to 1% with placebo, which the company said was around twice the level achieved with Wegovy ... in the STEP 9 trial.

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

Wegovy belongs to a drug class called glucagon-like peptide-1 (GLP-1) agonists ... To view complete step-by-step dosing instructions for using Wegovy pens, view this guide from the drug’s ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now. By Rebecca Robbins It’s easy to make a medical case for ...

Drugmaker Novo Nordisk's supply of the popular GLP-1 prescriptions ... to make Ozempic and Wegovy. The shortage allowed compounding pharmacies and other companies to step in and fill supply ...

The company has already outlined plans for a new Phase 3 trial to test whether CagriSema can generate greater weight loss at higher doses. Novo had an early lead on Lilly, with Wegovy reaching ...

Novo Nordisk said game on, as the Denmark-based drugmaker lowered prices on its obesity treatment Wegovy for those without insurance, and said it would deliver the drug to their homes. Tomi ...

Blockbuster weight-loss and diabetes drugs Wegovy ... GLP-1 drugs had been in shortage since 2022 due to increased demand, and a law allowed compounding pharmacies to step in to fill supply ...